Parthenolide as an Experimental Antifibrotic Agent: Mechanistic Insights and Therapeutic Prospects in Renal Fibrosis. Cuestiones de Fisioterapia, [S. l.], v. 53, n. 03, p. 6582–6589, 2024. DOI: 10.48047/bbn77w83. Disponível em: https://cuestionesdefisioterapia.com/index.php/es/article/view/3876.. Acesso em: 14 apr. 2026.